S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways

Clinical and Experimental Immunology

Volumn 173, Issue 3, 2013, Pages 523-535

  Xu, X ^a,c   Chen, H ^a,c   Zhu, X ^a,c   Ma, Y ^b   Liu, Q ^b   Xue, Y ^a,c   Chu, H ^b   Wu, W ^a   Wang, J ^b,c   Zou, H ^a,c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

ERK1 2; Human fetal lung fibroblasts; Inflammation; Lung fibrosis; NF B; RAGE; S100A9

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA SMOOTH MUSCLE ACTIN; CALGRANULIN B; COLLAGEN TYPE 3; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL ACTIVATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROBLAST; LUNG FIBROSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ERK1/2; HUMAN FETAL LUNG FIBROBLASTS; INFLAMMATION; LUNG FIBROSIS; NF-ΚB; RAGE; S100A9;

ACTINS; CALGRANULIN B; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION MEDIATORS; LUNG; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84881527844     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12139     Document Type: Article

References (42)

1. Latsi PI, du Bois RM, Nicholson AG etal. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168:531-537.
2. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33:637-668.
3. Kerkhoff C, Klempt M, Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1998; 1448:200-211.
4. Schafer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996; 21:134-140.
5. Hessian PA, Edgeworth J, Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol 1993; 53:197-204.
6. Vogl T, Ludwig S, Goebeler M etal. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 2004; 104:4260-4268.
7. Simard JC, Girard D, Tessier PA. Induction of neutrophil degranulation by S100A9 via a MAPK-dependent mechanism. J Leukoc Biol 2010; 87:905-914.
8. Perera C, McNeil HP, Geczy CL. S100 Calgranulins in inflammatory arthritis. Immunol Cell Biol 2010; 88:41-49.
9. Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004; 344:37-51.
10. Foell D, Wittkowski H, Ren Z etal. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol 2008; 216:183-192.
11. Foell D, Hernandez-Rodriguez J, Sanchez M, Vogl T, Cid MC, Roth J. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J Pathol 2004; 204:311-316.
12. Lovell DJ, Ruth NM. Pediatric clinical research. Curr Opin Rheumatol 2005; 17:265-270.
13. Korthagen NM, Nagtegaal MM, van Moorsel CH, Kazemier KM, van den Bosch JM, Grutters JC. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases. Clin Exp Immunol 2010; 161:342-347.
14. Hara A, Sakamoto N, Ishimatsu Y etal. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis. Respir Med 2012; 106:571-580.
15. Bargagli E, Olivieri C, Cintorino M etal. Calgranulin B (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis? Inflammation 2011; 34:85-91.
16. Fietta A, Bardoni A, Salvini R etal. Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res Ther 2006; 8:R160.
17. Phan SH. The myofibroblast in pulmonary fibrosis. Chest 2002; 122:286S-289.
18. Lawson WE, Polosukhin VV, Zoia O etal. Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med 2005; 171:899-907.
19. Hashimoto D, Ohmuraya M, Hirota M etal. Involvement of autophagy in trypsinogen activation within the pancreatic acinar cells. J Cell Biol 2008; 181:1065-1072.
20. Tang CH, Yang RS, Chen YF, Fu WM. Basic fibroblast growth factor stimulates fibronectin expression through phospholipase C gamma, protein kinase C alpha, c-Src, NF-kappaB, and p300 pathway in osteoblasts. J Cell Physiol 2007; 211:45-55.
21. Ghavami S, Rashedi I, Dattilo BM etal. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 2008; 83:1484-1492.
22. Shibata F, Miyama K, Shinoda F, Mizumoto J, Takano K, Nakagawa H. Fibroblast growth-stimulating activity of S100A9 (MRP-14). Eur J Biochem 2004; 271:2137-2143.
23. Ahmad A, Bayley DL, He S, Stockley RA. Myeloid related protein-8/14 stimulates interleukin-8 production in airway epithelial cells. Am J Respir Cell Mol Biol 2003; 29:523-530.
24. Schelbergen RF, Blom AB, van den Bosch MH etal. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Arthritis Rheum 2012; 64:1477-1487.
25. Baillet A. [S100A8, S100A9 and S100A12 proteins in rheumatoid arthritis]. Rev Med Interne 2010; 31:458-461.
26. Bierhaus A, Humpert PM, Morcos M etal. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 2005; 83:876-886.
27. He M, Kubo H, Ishizawa K etal. The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2007; 293:L1427-1436.
28. Liang X, So YH, Cui J etal. The low-dose ionizing radiation stimulates cell proliferation via activation of the MAPK/ERK pathway in rat cultured mesenchymal stem cells. J Radiat Res 2011; 52:380-386.
29. Ikeda F, Matsubara T, Tsurukai T, Hata K, Nishimura R, Yoneda T. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts. J Bone Miner Res 2008; 23:907-914.
30. Ramasamy R, Yan SF, Schmidt AM. RAGE: therapeutic target and biomarker of the inflammatory response - the evidence mounts. J Leukoc Biol 2009; 86:505-512.
31. Gao B, Wang Y, Tsan MF. The heat sensitivity of cytokine-inducing effect of lipopolysaccharide. J Leukoc Biol 2006; 80:359-366.
32. Shibata F, Ito A, Ohkuma Y, Mitsui K. Mitogenic activity of S100A9 (MRP-14). Biol Pharm Bull 2005; 28:2312-2314.
33. Kienast K, Knorst M, Muller-Quernheim J, Ferlinz R. Modulation of IL-1 beta, IL-6, IL-8, TNF-alpha, and TGF-beta secretions by alveolar macrophages under NO2 exposure. Lung 1996; 174:57-67.
34. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003; 170:3233-3242.
35. Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 2003; 171:2602-2609.
36. Hussein MR, Hassan HI, Hofny ER etal. Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis. J Clin Pathol 2005; 58:178-184.
37. Green FH. Overview of pulmonary fibrosis. Chest 2002; 122:334S-339.
38. Willis BC, Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293:L525-534.
39. Gebhardt C, Riehl A, Durchdewald M etal. RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 2008; 205:275-285.
40. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 2006; 19:1437-1445.
41. Queisser MA, Kouri FM, Konigshoff M etal. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. Am J Respir Cell Mol Biol 2008; 39:337-345.
42. Stern D, Yan SD, Yan SF, Schmidt AM. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 2002; 54:1615-1625.